1. R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study. Issue 3 (March 2018) Authors: Barr, Paul M; Li, Hongli; Burack, W Richard; LeBlanc, Michael; Smith, Sonali M; Gopal, Ajay K; Floyd, Justin D; Persky, Daniel O; Press, Oliver W; Fisher, Richard I; Friedberg, Jonathan W Journal: Lancet Issue: Volume 5:Issue 3(2018) Page Start: e102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study. Issue 4 (April 2022) Authors: Casulo, Carla; Larson, Melissa C; Lunde, Julianne J; Habermann, Thomas M; Lossos, Izidore S; Wang, Yucai; Nastoupil, Loretta J; Strouse, Christopher; Chihara, Dai; Martin, Peter; Cohen, Jonathon B; Kahl, Brad S; Burack, W Richard; Koff, Jean L; Mun, Yong; Masaquel, Anthony; Wu, Mei; Wei, Michael ... Journal: Lancet Issue: Volume 9:Issue 4(2022) Page Start: e289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗